199 related articles for article (PubMed ID: 9925501)
1. [Taxotere in various solid tumors].
Orel NF
Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501
[No Abstract] [Full Text] [Related]
2. Docetaxel: a review of its pharmacology and clinical activity.
Trudeau ME
Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel (Taxotere) in the treatment of cancer.
Burris HA
Semin Oncol; 2000 Apr; 27(2 Suppl 3):1-2. PubMed ID: 10810931
[No Abstract] [Full Text] [Related]
4. Clinical trials referral resource. Clinical trials with taxol.
Cheson BD
Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
[No Abstract] [Full Text] [Related]
5. The development of docetaxel (Taxotere) in non-small cell lung cancer.
Kris MG; Miller VA; Ng KK; Grant SC
Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
[No Abstract] [Full Text] [Related]
6. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
Kris MG; Millward M
Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
[No Abstract] [Full Text] [Related]
7. [Evidence for Taxotere treatment with solid tumors].
Saeki T; Takashima S; Sasaki Y; Ito K; Igarashi T; Minami H; Fujii H; Ishizawa K; Kubota K; Imoto S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1288-93. PubMed ID: 10945028
[TBL] [Abstract][Full Text] [Related]
8. The current management of malignancy -- VI other solid tumors.
Panettiere FJ
Alaska Med; 1977 Mar; 19(2):19-25. PubMed ID: 326087
[No Abstract] [Full Text] [Related]
9. Role of taxanes in lung-cancer chemotherapy.
Schiller JH
Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
[No Abstract] [Full Text] [Related]
10. [Taxenes: a new hope of clinical oncology in the 90-ies].
Shparik IV
Vopr Onkol; 1995; 41(1):7-12. PubMed ID: 7667946
[No Abstract] [Full Text] [Related]
11. [Paclitaxel].
Díaz M; Campanero MA
Rev Med Univ Navarra; 1996; 40(3):43-51. PubMed ID: 9499826
[No Abstract] [Full Text] [Related]
12. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: recent results and future developments.
Rosell R
Semin Oncol; 1999 Jun; 26(3 Suppl 11):1-3. PubMed ID: 10458202
[No Abstract] [Full Text] [Related]
13. Paclitaxel: current developmental approaches of the National Cancer Institute.
Arbuck SG
Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
15. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
Fossella FV; Lee JS; Berille J; Hong WK
Semin Oncol; 1995 Apr; 22(2 Suppl 4):22-9. PubMed ID: 7740327
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel (Taxotere) in the treatment of solid tumors other than breast and lung cancer.
Kaye SB
Semin Oncol; 1995 Apr; 22(2 Suppl 4):30-3. PubMed ID: 7740329
[TBL] [Abstract][Full Text] [Related]
17. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
Fossella FV
Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
[TBL] [Abstract][Full Text] [Related]
18. The taxanes: an update.
Crown J; O'Leary M
Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
[TBL] [Abstract][Full Text] [Related]
19. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
[No Abstract] [Full Text] [Related]
20. Docetaxel in the management of advanced non-small cell lung cancer.
Miller VA
Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]